Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 119 of 144 pages ‹ First < 117 118 119 120 121 > Last ›
HSL9771
European reforms will speed up access to new drugs
Pharmaceutical Journal 2004; 272:(7282):47
HSL9772
Guidance for brand name prescriptions updated
Pharmaceutical Journal 2004; 272:(7282):46
HSL9773
Preedy V, Mantle D.
Adverse effect on coenzyme Q10 levels [2]
Pharmaceutical Journal 2004; 272:(7281):13
HSL9774
Bellingham C.
Is pharmacy ready for OTC statins?
Pharmaceutical Journal 2004; 272:(7281):8-9
HSL9775
Spending rates for dementia drugs still vary
Pharmaceutical Journal 2004; 272:(7281):
HSL9776
'Medicamentation' of society: An example of social pharmacology
Prescrire International 2004; 13:(69):38
HSL9778
Lexchin J.
Are new drugs as good as they claim to be?
Australian Prescriber 2004; 27:(1):2-3
HSL9782
Luggen ME.
Trials Are Short, Disease Long: Measuring Drug Utility Beyond Clinical Trials
Journal of Rheumatology 2004; 31:(2):205-6
HSL9785
O'Connell B.
Going off Patent: Standing Pat or Getting Out
BioPharm International 2004; 17:(1):26, 28
HSL9786
Wechsler J.
Medicare Bill Boosts Coverage for Biotech Therapies
BioPharm International 2004; 17:(1):20, 22
HSL9788
Huang SM, Hall SD, Watkins P, Love LA, Serabjit-singh C, Betz JM, Hoffman FA, Honig P, Coates PM, Bull J, Chen ST, Kearns GL, Murray MD.
Drug interactions with herbal products and grapefruit juice: A conference report
Clinical Pharmacology and Therapeutics 2004; 71:(1):1-12
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/j.clpt.2003.07.002
HSL9791
Barlas S.
Major Changes Ahead: Medicare Drug Benefit to Affect the Entire Drug-Distribution Chain
P and T 2004; 29:(1):13
HSL9792
Nash DB.
Countering Counterfeiters
P and T 2004; 29:(1):10-11
HSL9875
Pursuing a career in medical sales
Nature Reviews Drug Discovery 2004; 3:(1):97-98
HSL9877
Circles to square on medicines
Veterinary Record 2004; 154:(2):33
HSL9878
Calaf J, Ferrer M.
Pharmacological treatment of menopause in Spain in 2002
Clinica e Investigacion en Ginecologia y Obstetricia 2004; 30:(9):299-306
HSL11251
Medawar C, Herxheimer A.
A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine
The International Journal of Risk and Safety in Medicine 2004; 16:(1):5-19
http://iospress.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,3,8;journal,12,26;linkingpublicationresults,1:103162,1;
HSL11531
DiMasi JA, Paquette C.
The economics of follow-on drug research and development: trends in entry rates and the timing of development.
Pharmacoeconomics 2004; 22:((2 Suppl 2)):1-14.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15660473
HSL11562
Grabowski H.
Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures
Pharmacoeconomics 2004; 22:((2 Suppl 2)):15-24.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=15660474
HSL12480
Phillips BJ, McQuarrie EF.
Beyond Visual Metaphor: A New Typology of Visual Rhetoric in Advertising
Marketing Theory 2004; 4:(1-2):113-136
http://mtq.sagepub.com/cgi/content/abstract/4/1-2/113?ck=nck
HSL13552
von Hippel A
Better Health Care At Half The Cost
: Xlibris Corporation 2004
http://www2.xlibris.com/bookstore/bookdisplay.asp?bookid=24928
HSL14879
Ashcroft RE.
Current epistemological problems in evidence based medicine.
J Med Ethics 2004; 30:131–135
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1733829&blobtype=pdf
HSL15098
Rasmussen N.
The Moral Economy of the Drug Company–Medical Scientist Collaboration in Interwar America
Social Studies of Science 2004; 34:(2):161-185
http://sss.sagepub.com/cgi/content/abstract/34/2/161
HSL15100
Healy D.
Shaping the Intimate:: Influences on the Experience of Everyday Nerves
Social Studies of Science 2004; 34:(2):219-245
http://sss.sagepub.com/cgi/content/abstract/34/2/219
HSL15542
Quick J, Dé A.
Update to the Direct-to-Consumer Debate: The Risks and Benefits of Pharmaceutical Promotion Across the Atlantic
Public Relations Strategist 2004; 10:(2):29-31
http://www.prsa.org/publications/strategist/
HSL16338
Even P, Debré B
Savoir et Pouvoirs Paris: Le Cherche Midi 2004
http://www.eyrolles.com/Entreprise/Livre/savoirs-et-pouvoirs-9782749102498
HSL16341
Hadler N
The Last Well Person: How to stay well despite the health-care system. Montreal-Kingston: McGill-Queens University Press 2004
http://books.google.com.au/books?id=kTjV7urN8h8C&dq=Hadler,+Nortin.+The+Last+Well+Person:+How+to+stay+well+despite+the+health-care+system.&source=gbs_navlinks_s
HSL16346
Medawar C, Hardon A
Medicines out of Control? Antidepressants and the conspiracy of goodwill. Netherlands: Aksant 2004
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1079538
HSL16349
Saint-Onge JC
L’envers de la pilule: Les dessous de l’industrie pharmaceutique. Montréal: õcosociété 2004
http://www.livresquebecois.com/livre.asp?id=pzobfyugobfug&/l-envers-de-la-pilule-nouvelle-edition/jean-claude-st-onge
HSL16524
Kaiser T, Ewers H, Waltering A, Beckwermert D, Jennen C, Sawicki PT
Sind die Aussagen medizinischer Werbeprospekte korrekt?
Arznei Telegramm 2004; 35:(21):3
www.di-em.de/data/at_2004_35_21.pdf
HSL16528
Huff-Rousselle M.
Book review: How to Develop and Implement a National Drug Policy.
Int J Health Plann Mgmt 2004; 19:1–2
HSL16798
Glass HE.
Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?
Dis Manag 2004 Spr; 7:(1):77-87
http://www.liebertonline.com/doi/abs/10.1089/109350704322919014
HSL18036
Collier J
Regulating the regulators
Lancet 2004; 363:(9427):2199-2199
http://linkinghub.elsevier.com/retrieve/pii/S014067360416529X
HSL18038
Spurgeon D
US junior doctors found to be ignorant of drug companies' tactics
BMJ 2004; 328:(7447):1032
http://www.bmj.com/cgi/content/full/328/7447/1032-a
HSL18039
Harvey K
Website review: AdWatch web site
Aust Prescr 2004; 27:(3):63
http://www.australianprescriber.com/index.php?content=/agazines/vol27no3/63_websitereview.htm
HSL18177
Fava GA
Conflict of Interest in Psychopharmacology: Can Dr. Jekyll Still Control Mr. Hyde?
Psychother Psychosom 2004; 73:1-4
http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000074433
HSL19046
Caudill-Slosberg MA, Schwartz LM, Woloshin S
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs.2000.
Pain 2004; 109:(3):514-9
http://www.painjournalonline.com/article/S0304-3959(04)00130-7/abstract
HSL19387
Donohue JM, Berndt ER
Effects of direct-to-consumer advertising on medication choice: the case of anti-depressants
Journal of Public Policy & Marketing 2004; 23:(2):115-127
http://www.kff.org/rxdrugs/upload/Effects-of-Direct-to-Consumer-Advertising-on-Medication-Choice-the-Case-of-Antidepressants.pdf
HSL19390
Manchanda P, Rossi P, Chintagunta P
Response modeling with nonrandom marketing-mix variables
J Marketing Res 2004; 41:467–478
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=371360
HSL19286
Vadodara/ Bilaspur
Impoverishing the Poor: Pharmaceuticals and Drug Pricing in India : LOCOST/JSS 20040
http://www.scribd.com/my_document_collections/2879052
HSL19511
Bellin M, McCarthy S, Drevlow L, Pierach C.
Medical students' exposure to pharmaceutical industry marketing: a survey at one US medical school
Academic Medicine 2004; 79:(11):1041-5
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=NxpFhX0RqlgMjcQZTwGJ3ngkLPpGZCNQPXqnKHLKYpXzVqQGgyhh!1776764395!181195628!8091!-1?issn=1040-2446&volume=79&issue=11&spage=1041
HSL19515
Light D, Lexchin J
Will lower drug prices jeoparidize drug research? A policy fact sheet
The American Journal of Bioethics 2004; 4:(1):
http://bioethics.net/journal/j_articles.php?aid=61
HSL19918
Casey R
Designing Brand Identity: A Complete Guide to Creating, Building, and Maintaining Strong Brands
Journal of the Academy of Marketing Science 2004; 23:(1):100-101
http://jam.sagepub.com/content/32/1/100.extract
HSL19974
The Evolving Environment For Prescription Drugs
Health Affairs 2004; 23:(1):51
content.healthaffairs.org/content/23/1/51.full
HSL19993
Gebbie KM
Profitable Pills
AIDS Reader 2004; 14:(106):109
http://www.medscape.com/viewarticle/472296
HSL20026
Jawaid SA, Jafary MH
Relationship between the medical profession and the pharma industry: Need for greater scrutiny, transparency and accountability
Pak J Med Sci 2004; 20:(4):283-291
http://www.scribd.com/doc/31273862/Relationship-Between-the-Medical-Profession-AND-THE-PHARMA-INDUSTRY
HSL20190
Hochhauser M
Consumer-Friendly Patient Information Should Replace DTC Brief Summaries.
Product Management Today 2004; 15:(1):26-28
HSL1549
Hughes G.
Drug giant linked to immunisation campaign
The Age 2003 Dec 22
http://www.theage.com.au/articles/2003/12/21/1071941610958.html
HSL195
McCarthy M.
NIH told to provide records in conflict of interest probe.
Lancet 2003 Dec 20; 362:(9401):2076
http://web.archive.org/web/20041228074016/http://www.thelancet.com/journal/vol362/iss9401/abs/llan.362.9401.news.28183.1
HSL196
Sackett DL, Oxman AD; HARLOT plc.
HARLOT plc: an amalgamation of the world's two oldest professions.
BMJ 2003 Dec 20; 327:(7429):1442-5
http://bmj.bmjjournals.com/cgi/content/full/327/7429/1442
HSL2161
Jefferson T, Shashok K, Wager E.
Get peered!
2003; 327:(7429):1439-41
http://bmj.bmjjournals.com/cgi/content/full/327/7429/1439
HSL9887
Brocvielle H, Muret P, Plenat E, Kantelip JP, Humbert P.
Management of a patient receiving thalidomide
Presse Med. 2003 Dec 20; 32:(40):1894-8
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=100&CodeRevue4=PM&Path=REVUE/PM/2003/32/40/ARTICLE1110875240.xml&Locations=
HSL18044
Burls A, Sandercock J.
How to make a compelling submission to NICE: tips for sponsoring organisations.
BMJ 2003 Dec 20; 327:(7429):1446-8
http://www.bmj.com/cgi/pdf_extract/327/7429/1446
HSL20358
Currie C
Clinical arithmetic: An Enlightenment legacy still needs defending—against more subtle adversaries
BMJ 2003 Dec 20; 327:(7429):
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC300788/
HSL1547
U-M study: Doctors more likely to prescribe pricey new blood pressure drugs: Free drug samples may influence doctors' choices, researcher suggests
University of Michigan Health System 2003 Dec 19
HSL1548
Agovino T.
Rough flu season highlights economic problems of vaccine industry
Canadian Press 2003 Dec 19
HSL13306
Richard O, Van Horn L.
Persistence in prescriptions of branded drugs
International Journal of Industrial Organization 2003 Dec 19; 22:(4):523-540
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8P-4B8BST2-1&_user=10&_coverDate=04%2F30%2F2004&_rdoc=5&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235876%232004%23999779995%23490895%23FLA%23display%23Volume)&_cdi=5876&_sort=d&_docanchor=&_ct=9&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=f83412caf487e79e0bebbdd221ef44f4
HSL2
Komesaroff P.
Doctors, drugs and ethics
The Age 2003 Dec 18
http://www.theage.com.au/articles/2003/12/17/1071337024455.html?from=storyrhs
HSL3
Hughes G.
Drug firm linked to cancer group
The Age 2003 Dec 18
HSL1545
Baker B.
U.S.'s Misguided and Bad-Faith Attack on the WHO's 3-by-5 Plan
IP-Health 2003 Dec 18
HSL1546
Harris G.
States Try to Limit Drugs in Medicaid, but Makers Resist
New York Times 2003 Dec 18
http://www.nytimes.com/2003/12/18/business/states-try-to-limit-drugs-in-medicaid-but-makers-resist.html
HSL18045
Blumethal D
Academic–Industrial Relationships in the Life Sciences
NEJM 2003 Dec 18; 349:(25):2452
http://intl-content.nejm.org/cgi/content/full/349/25/2452
HSL4
A different kind of drug problem
The Age 2003 Dec 17
HSL1542
Kolata G.
A Contraceptive Clears a Hurdle to Wider Access
The New York Times 2003 Dec 17
http://www.nytimes.com/2003/12/17/us/a-contraceptive-clears-a-hurdle-to-wider-access.html
HSL1543
Arbor A.
Drug company fees for FDA reviews haven't accelerated approvals, study finds: Study also fails to find evidence of approval bias favoring big drug companies
2003 Dec 17
HSL1544
World Medical Association Press Release: Urgent Need For New Drugs In Sub Saharan Africa, Says WMA President
2003 Dec 17
HSL6260
World Medical Association
Urgent need for new drugs in sub Saharan Africa, says WMA President
World Medical Association 2003 Dec 17
http://web.archive.org/web/20080511231653/http://www.wma.net/e/press/2003_24.htm
HSL19924
Lundberg GD
Uninvited, Unwelcome Medical Email Message
MedScape 2003 Dec 16; 5:(4):
http://www.medscape.com/viewarticle/465734
HSL5
Hawaleskha D.
Viagra's New Competition: The little blue pill faces its rivals as men flock to boost their sex lives
McLeans.ca 2003 Dec 15
HSL6
Minchin L, Hughes G.
Push for action on drug firms
The Age 2003 Dec 15
http://www.theage.com.au/articles/2003/12/14/1071336810347.html?from=storyrhs
HSL1541
Elliott C.
Not-So-Public Relations: How the drug industry is branding itself with bioethics.
MSN Slate 2003 Dec 15
http://www.slate.com/id/2092442/
HSL1539
Gilpin K.
The Winners in the Medicare Bill, and Why
The New York Times 2003 Dec 14
HSL1536
Hughes G, Minchin L.
Drug giants' big-money pitch exposed
The Age 2003 Dec 13
http://www.theage.com.au/articles/2003/12/12/1071125659634.html?from=storyrhs
HSL1537
Hughes G.
Taking your medicine
The Age 2003 Dec 13
http://www.theage.com.au/articles/2003/12/12/1071125658355.html
HSL1538
Hughes G.
Drug firms fund disease awareness
Sydney Morning Herald 2003 Dec 13
http://www.smh.com.au/articles/2003/12/12/1071125652945.html
HSL7347
Ellner A.
Rethinking prescribing in the United States.
BMJ 2003 Dec 13; 327:(7428):1397-400
http://www.bmj.com/cgi/content/full/327/7428/1397
HSL9890
Garattini S, Garattini L.
Drug sales in four European countries still differ.
BMJ 2003 Dec 13; 327:(7428):1404-5
http://www.bmj.com/cgi/content/full/327/7428/1404-c
HSL18048
Dyer O
City reacts negatively as GlaxoSmithKline announces plans for new drugs
BMJ 2003 Dec 13; 327:(7428):1366
http://www.bmj.com/cgi/reprint_abr/327/7428/1366
HSL18049
Gibson L
Medicines agency introduces greater transparency
BMJ 2003 Dec 13; 327:(7428):1368
http://www.bmj.com/cgi/content/extract/327/7428/1368-d
HSL18050
Burton B
Australian government tries to stop independent advice on diabetes drugs
BMJ 2003 Dec 13; 327:(7428):1368
http://www.bmj.com/cgi/content/extract/327/7428/1368-g
HSL1535
Some Consumer Ads for Aventis' Taxotere Misleading, U.S. FDA Charges
Reuters 2003 Dec 12
HSL1540
Bates D.
The Medicare Morass: Many seniors upset about changes to federal program
The News-Register 2003 Dec 12
HSL1533
Mahoney J.
Leading vitamin scientist faces fire over data
The Globe and Mail 2003 Dec 11
HSL1534
Bramham D.
Depressed Kids: The Drug Debate: Are the young used as guinea pigs for untested antidepressants?
Sterling News Service 2003 Dec 11
HSL7
Blumenstyk G.
2 Congressmen Take Aim at NIH Officials' Consulting Deals With Drug Companies
The Chronicle of Higher Education 2003 Dec 10
HSL1532
Boseley S.
Drugs for depressed children banned
The Guardian 2003 Dec 10
http://www.guardian.co.uk/science/2003/dec/10/drugs.sciencenews
HSL8
Dobade G
Drug price control: no relief for poor
Deccan Herald 2003 Dec 09
HSL1531
Willman D.
Records of Payments to NIH Staff Sought: Two congressmen ask health institutes' leader to detail researchers' links to drug companies.
LA Times 2003 Dec 9
http://articles.latimes.com/2003/dec/09/nation/na-nih9
HSL11630
Kauffman JM.
Statin Drugs: A Critical Review of the Risk/Benefit Clinical Research
Recoverymedicine.com 2003 Dec 9
http://www.recoverymedicine.com/cholesterol_lowering_drug_side_effects.htm
HSL1529
Connor S.
Glaxo chief: Our drugs do not work on most patients
Independent news 2003 Dec 8
http://www.independent.co.uk/news/science/glaxo-chief-our-drugs-do-not-work-on-most-patients-575942.html
HSL1527
Willman D.
Stealth Merger: Drug Companies and Government Medical Research
LA Times 2003 Dec 7
http://articles.latimes.com/2003/dec/07/nation/na-nih7
HSL1528
Barnett A.
Revealed: how drug firms 'hoodwink' medical journals: Pharmaceutical giants hire ghostwriters to produce articles - then put doctors' names on them
The Observer 2003 Dec 7
HSL44
Tesoriero H
Torrid Drug-Price Increases Pause AARP Reports 0.5% Rise On Average in 3rd Quarter; Steeper Gains May Loom
The Wall Street Journal 2003 Dec 6
HSL1526
Westphal S.
You're my wife?
New Scientist 2003 Dec 6
http://www.newscientist.com/article/mg18024241.500-youre-my-wife.html
HSL18052
Ahmad K.
USA-Morocco deal may extend drug patents to 30 years.
Lancet 2003 Dec 6; 362:(9399):1904
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)15006-4
HSL1525
Fidelman C.
Druggists probed for illegal gifts: Order investigates. Kickbacks from pharmaceutical firms might have included loans, houses, trips
The Montreal Gazette 2003 Dec 5
HSL1522
Meikle J.
Ban for HRT in cancer warning: 'Wonder' drug no longer first choice for osteoporosis
The Guardian 2003 Dec 4
http://www.guardian.co.uk/uk/2003/dec/04/health.healthandwellbeing
HSL1523
Big Pharma:The benefits of hypertension: Growing pressure on pharmaceutical firms is a force for good
The Economist 2003 Dec 4
HSL1524
The drugs industry: Big trouble for Big Pharma: Why Big Pharma urgently needs a new business model
The Economist 2003 Dec 4
HSL9896
Zuger A.
Rx: Canadian drugs.
N Engl J Med 2003 Dec 4; 349:(23):2188-90
http://content.nejm.org/cgi/content/extract/349/23/2188
Page 119 of 144 pages ‹ First < 117 118 119 120 121 > Last ›
